<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Neuroretinitis associated with covid-19 infection and varicella-zoster virus reactivation</dc:title><dc:creator>Gavrič,	Ana Uršula	(Avtor)
	</dc:creator><dc:creator>Mylemans,	Evelien Margareta	(Avtor)
	</dc:creator><dc:creator>Vidović Valentinčič,	Nataša	(Avtor)
	</dc:creator><dc:subject>Neuroretinitis</dc:subject><dc:subject>covid-19</dc:subject><dc:subject>infection</dc:subject><dc:description>Purpose: To report a case of neuroretinitis as the presenting manifestation of COVID-19 infection alongside VZV reactivation, in the absence of other systemic symptoms. Methods: A case report. Results: A previously healthy 15-year-old male presented with a one-week history of acute unilateral visual loss and clinical findings consistent with neuroretinitis. Diagnostic work-up revealed a positive nasopharyngeal swab PCR for COVID-19 and serology showed the presence of IgM and IgG antibodies for VZV. Following a comprehensive treatment regimen involving intravenous acyclovir, high-dose intravenous steroids and oral doxycycline, rapid and remarkable improvements were observed. The macular star and optic disc swelling regressed, and visual acuity improved from 20/200 to 20/20. Conclusion: This case offers valuable insights into the neuroretinitis associated with COVID-19 infection and VZV reactivation.</dc:description><dc:date>2026</dc:date><dc:date>2026-03-16 11:35:56</dc:date><dc:type>Neznano</dc:type><dc:identifier>28378</dc:identifier><dc:identifier>UDK: 617.7:616.9</dc:identifier><dc:identifier>ISSN pri članku: 1937-1578</dc:identifier><dc:identifier>DOI: 10.1097/ICB.0000000000001694</dc:identifier><dc:identifier>COBISS_ID: 232928771</dc:identifier><dc:language>sl</dc:language></metadata>
